Integrated budget impact model to estimate the impact of introducing selpercatinib as a tumor-agnostic treatment option for patients with RET-altered solid tumors in the US
Article in Journal of Medical Economics (March 2024)
The most recent citing publications are shown below. View all 37 publications that cite this research output on Dimensions.
Article in Journal of Medical Economics (March 2024)
Article in JTO Clinical and Research Reports (February 2024)
Article in JCO Precision Oncology (January 2024)